Hanol IP & Law

Min Son of Hanol IP & Law explains that the regime will limit extensions to one patent per approval and cap extended periods at 14 years from the date of marketing authorisation

Min Son of Hanol IP & Law says pharmaceutical R&D in South Korea should be enhanced on the introduction of a clearer legal framework that offers improved market protection for new and modified drugs

Min Son of Hanol IP & Law examines a new consent agreement system and international trademark partial replacement provisions under South Korea’s revised Trademark Act, and explores the concept of ‘identical trademarks’

Min Son of Hanol IP & Law reports on a decision that should provide improved guidance in determining whether patents or approved drugs are eligible for a patent term extension in South Korea

Min Son of Hanol IP & Law says South Korea is ploughing its energies into shortening the patent examination process for the secondary battery industry to help the country’s powerhouses maintain their charge

Min Son of Hanol IP & Law explains why strategic trademark management plans have become more important than ever as a new system is brought in to address the issue of senior conflicting mark rejections